[HTML][HTML] The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease

Y Döring, L Pawig, C Weber, H Noels - Frontiers in physiology, 2014 - frontiersin.org
The chemokine receptor CXCR4 and its ligand CXCL12 play an important homeostatic
function by mediating the homing of progenitor cells in the bone marrow and regulating their …

Emerging importance of chemokine receptor CXCR3 and its ligands in cardiovascular diseases

R Altara, M Manca, RD Brandão, A Zeidan… - Clinical …, 2016 - portlandpress.com
The CXC chemokines, CXCL4,-9,-10,-11, CXCL4L1, and the CC chemokine CCL21,
activate CXC chemokine receptor 3 (CXCR3), a cell-surface G protein-coupled receptor …

Vascular CXCR4 limits atherosclerosis by maintaining arterial integrity: evidence from mouse and human studies

Y Döring, H Noels, EPC Van Der Vorst, C Neideck… - Circulation, 2017 - Am Heart Assoc
Background: The CXCL12/CXCR4 chemokine ligand/receptor axis controls (progenitor) cell
homeostasis and trafficking. So far, an atheroprotective role of CXCL12/CXCR4 has only …

The multifaceted functions of CXCL10 in cardiovascular disease

P van den Borne, PHA Quax, IE Hoefer… - BioMed research …, 2014 - Wiley Online Library
C‐X‐C motif ligand 10 (CXCL10), or interferon‐inducible protein‐10, is a small chemokine
belonging to the CXC chemokine family. Its members are responsible for leukocyte …

[HTML][HTML] The role of CXCR3 and associated chemokines in the development of atherosclerosis and during myocardial infarction

V Szentes, M Gazdag, I Szokodi, CA Dézsi - Frontiers in immunology, 2018 - frontiersin.org
The chemokine receptor CXCR3 and associated CXC chemokines have been extensively
investigated in several inflammatory and autoimmune diseases as well as in tumor …

CXCR3-binding chemokines: novel multifunctional therapeutic targets

E Lazzeri, P Romagnani - Current Drug Targets-Immune …, 2005 - ingentaconnect.com
The goal to attenuate inflammation without inducing generalized immunosuppression has
focused the attention on chemokines, a family of chemotactic peptides that regulate the …

Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases

K Dhayni, K Zibara, H Issa, S Kamel… - Pharmacology & …, 2022 - Elsevier
CXCR1 and CXCR2 chemokine receptors, mainly activated by interleukin 8 (IL-8 or CXCL8),
are expressed in a variety of cells including, leukocytes, fibroblasts, endothelial cells, and …

Loss of endothelial CXCR7 impairs vascular homeostasis and cardiac remodeling after myocardial infarction: implications for cardiovascular drug discovery

H Hao, S Hu, H Chen, D Bu, L Zhu, C Xu, F Chu… - Circulation, 2017 - Am Heart Assoc
Background: Genome-wide association studies identified the association of the CXCL12
genetic locus (which encodes the chemokine CXCL12, also known as stromal cell–derived …

Regulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis

EL Gautier, C Jakubzick… - … , thrombosis, and vascular …, 2009 - Am Heart Assoc
Monocytes are central mediators in the advance of atherosclerotic plaque, making them a
natural therapeutic target for reducing disease burden. Here, we highlight recent advances …

Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis

A Zernecke, I Bot, Y Djalali-Talab… - Circulation …, 2008 - Am Heart Assoc
The CXC ligand (CXCL) 12/CXC receptor (CXCR) 4 chemokine–receptor axis controls
hematopoiesis, organ development, and angiogenesis, but its role in the inflammatory …